Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL7427434

CCCC(N)c1ccccn1.N

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA5 P22460 4/20 0.51
CYP2D6 P10635 2/20 0.51
KCNE1 P15382 1/20 0.51
KCNH2 Q12809 2/20 0.50
TSHR P16473 2/20 0.44
SLC6A2 P23975 3/20 0.42
SLC6A4 P31645 3/20 0.42
CHRM2 P08172 3/20 0.42
SCN1A P35498 2/20 0.42
SCN2A Q99250 2/20 0.42
SCN3A Q9NY46 2/20 0.42
ALDH1A1 P00352 2/20 0.41
CYP1A2 P05177 1/20 0.41
SLC6A3 Q01959 2/20 0.41
GRIN2D O15399 1/20 0.40
GRIN3B O60391 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2A Q12879 1/20 0.40
GRIN2B Q13224 1/20 0.40
GRIN2C Q14957 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL704576 0.98 KCNA5 (0.53) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL31482137 0.98 KCNA5 (0.53) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL23832945 0.98 KCNA5 (0.53) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL16768770 0.87 KCNA5 (0.50) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL5663826 0.86 KCNA5 (0.49) KCNA5CYP2D6KCNE1KCNH2TSHR
Ammonia Solution, Strong SCHEMBL7426262 0.85 KCNA5 (0.49) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL10693275 0.84 KCNA5 (0.47) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL27873703 0.84 KCNA5 (0.47) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL23114268 0.84 KCNA5 (0.47) KCNA5CYP2D6KCNE1KCNH2TSHR
SCHEMBL26487309 0.84 KCNA5 (0.47) KCNA5CYP2D6KCNE1KCNH2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1019050-B1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK AS (DK) 2002-03-20 EP disclosed
US-6159941-A Use of somatostatin agonists and antagonists for treating diseases related to the eye NOVO NORDISK A/S (DK) 2000-12-12 US disclosed
US-6127343-A SELECTIVE, COMPETITIVE SOMATOSTATIN RECEPTOR LIGANDS OF NONPEPTIDE ORIGIN, FOR MEDIATING THE BIOLOGICAL EFFECT OF SOMATOSTATIN AGONISTS OR ANTAGONIST NOVO NORDISK A/S (DK) 2000-10-03 US disclosed
EP-1019050-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 2000-07-19 EP disclosed
EP-0912551-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1999-05-06 EP disclosed
WO-1998058646-A1 USE OF SOMATOSTATIN AGONISTS AND ANTAGONISTS FOR TREATING DISEASES RELATED TO THE EYE NOVO NORDISK A/S (DK) 1998-12-30 WO disclosed
WO-1997043278-A1 SOMATOSTATIN AGONISTS AND ANTAGONISTS NOVO NORDISK A/S (DK) 1997-11-20 WO disclosed